Premium
Homeodomain protein DLX4 facilitates nasopharyngeal carcinoma progression via up‐regulation of YB‐1
Author(s) -
Ling Zeyi,
Long Xiaoli,
Li Jie,
Feng Mingliang
Publication year - 2020
Publication title -
genes to cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 115
eISSN - 1365-2443
pISSN - 1356-9597
DOI - 10.1111/gtc.12772
Subject(s) - gene knockdown , nasopharyngeal carcinoma , cancer research , chromatin immunoprecipitation , cell growth , downregulation and upregulation , biology , cell cycle , homeobox , cell , cell culture , medicine , transcription factor , radiation therapy , gene expression , gene , promoter , biochemistry , genetics
Nasopharyngeal carcinoma (NPC) is a malignant tumor in nasopharynx tissues and lacks effective treatment strategies. Dysregulation of distal‐less homeobox 4 (DLX4) participates in the development of tumors. Understanding the regulatory mechanism of DLX4 in NPC progression may address this issue. Here, we first identified an up‐regulation of DLX4 in NPC cell lines compared to normal epithelial cells. Data from colony formation and transwell assays showed that knockdown of DLX4 inhibited cell proliferation and invasion of NPC, respectively. Moreover, DLX4 knockdown blocked the cell cycle of NPC at G1 phase, suggesting the antitumor effect of DLX4 knockdown on NPC. The downstream target of DLX4 was identified as Y‐box binding protein 1 (YB‐1), whose expression was increased by over‐expression of DLX4, while decreased by knockdown of DLX4. The binding capacity between DLX4 and YB‐1 was verified by chromatin immunoprecipitation (ChIP), and the result showed that DLX4 could not directly bind to the promoter of YB‐1. Mechanically, YB‐1 over‐expression reversed the effects of DLX4 knockdown on cell proliferation, cell cycle arrest and cell invasion of NPC. In conclusion, our findings indicated that DLX4 promoted NPC progression via up‐regulation of YB‐1, which would shed light on therapeutic schedule in NPC.